The latest research into psilocybin therapy as a treatment for depression has yielded promising results.
Here are the doses they tried.
New research lends further credibility to anecdotes that microdosing lysergic acid diethylamide (LSD), or taking too little of the psychedelic drug to trip but enough to feel effects, can help your focus.
In the placebo-controlled study, published in the journal European Neuropsychopharmacology on Saturday, scientists from Switzerland’s University of Basel and the Netherlands’ Maastricht University gave volunteers either a small dose of LSD or a placebo, then measured their ability to pay attention and process information, as well as keeping an eye on their mood.
Like most psychedelics research, the study was somewhat small and limited, so any findings should be taken with a grain of salt. But the team of researchers did find clear differences between LSD dose levels, identifying lines at which LSD starts — and stops — being helpful.
A typical recreational dose of LSD typically starts at around 100 micrograms. But in this case, the doctors dialed it way back.
The study’s 24 volunteers — who reported having used psychedelics an average of 2.75 times before the experiment — were either given five, 10, or 20 micrograms of LSD, and a fourth group was given a placebo to make sure that any changes were caused by the drug itself. There were only six volunteers in each group, so a larger study will be necessary to validate this one’s findings, but this is also the first experiment to distinguish the variety of individual responses to each dose level.